Financial challenges faced by healthcare companies due to surplus COVID inventories leading to industry drop

From Barchart: 2025-04-18 09:02:00

Healthcare companies are facing financial challenges as they deal with surplus COVID inventories, leading to a 15.5% industry drop over the past six months. LifeStance Health Group (LFST) has a $2.58 billion market cap but faces issues with revenue base and operating margins, trading at 218.9x forward price-to-earnings. Quest (DGX) has an $18.18 billion market cap but struggles with soft demand and decreased efficiency, with a stock price of $163.61. GoodRx (GDRX) has a $1.72 billion market cap but shows slow revenue growth and negative returns on capital, trading at $4.49 per share.

In the midst of political and economic uncertainty, some companies remain poised for long-term growth. Check out the top 5 Strong Momentum Stocks for curated high-quality options that have generated a 175% market-beating return over the last five years. StockStory highlights successful picks from 2019, including Nvidia (+2,183% return) and United Rentals (+322% return). Explore potential winners for free with StockStory today.



Read more at Barchart: 3 Healthcare Stocks with Questionable Fundamentals